Hymecromone Tablets 200?mg (Fujian / Wanbangde)

Hymecromone Tablets 200?mg (Fujian / Wanbangde)

$3.00

Hymecromone Tablets (Fujian), manufactured by Wanbangde Pharmaceutical Group Co., Ltd., contain 200?mg of hymecromone per tablet. NMPA-approved under H13022246, this compound is widely studied for its cholagogue and hepatoprotective properties in research.
?? For laboratory and research use only.?Please consult staff for other specifications and uses?

EMI starting from $0.00/month - View Plans
Compare

Description

Hymecromone (also known as 4-methylumbelliferone or 4-MU) is a synthetic coumarin derivative commonly used in biomedical research, particularly for its choleretic, antifibrotic, and hepatoprotective properties. It is studied for stimulating bile secretion, reducing liver inflammation, and modulating hyaluronic acid synthesis.

This product contains 6 oral tablets, each delivering 200?mg of hymecromone. Manufactured under GMP standards in China by Wanbangde Pharmaceutical Group, it is approved by the NMPA (Chinese FDA) under H13022246.

? Ideal for use in liver function studies, hepatic fibrosis models, bile secretion assays, and pharmaceutical R&D.


Hymecromone Tablets Product Specifications

ParameterDetails
Product NameHymecromone Tablets (Fujian)
Generic NameHymecromone / 4-Methylumbelliferone
CAS Number90-33-5
Molecular FormulaC10H8O3
Molecular Weight176.17 g/mol
Strength200?mg per tablet
Dosage FormOral tablet
Pack Size6 tablets per box
Approval NumberH13022246 (NMPA)
Drug Code86902779000147
ManufacturerWanbangde Pharmaceutical Group Co., Ltd.
Barcode6920552403491
Storage ConditionsStore ? 25?°C in dry place; avoid direct sunlight
Intended UseFor lab R&D in hepatology, bile secretion, and fibrosis

Hymecromone Tablets Mechanism of Action

Hymecromone enhances bile acid secretion by inhibiting hyaluronic acid synthesis, reducing bile duct resistance, and improving bile flow. It also exhibits anti-inflammatory effects on hepatocytes and fibrotic tissues. This makes it a promising research compound for liver diseases, especially cholestasis, hepatofibrosis, and NAFLD models.


Research Applications

  • Hepatic fibrosis inhibition via hyaluronic acid modulation

  • Choleretic activity studies in experimental bile flow assays

  • NAFLD and liver injury models

  • Antifibrotic drug development screening

  • Liver inflammation suppression in chemically-induced models


Safety & Handling

  • Suggested Lab Use: Refer to institutional preclinical guidelines

  • Observed Adverse Reactions (in high dose models): Gastrointestinal upset, hypersensitivity

  • PPE Required: Gloves, mask, protective eyewear when handling

  • Shelf Life: 24–36 months when sealed and stored properly


Core  Keywords

Hymecromone tablets, 4-MU tablets, 4-methylumbelliferone 200mg, CAS 90-33-5, choleretic research compound, liver fibrosis model drug, bile secretion enhancer, hymecromone hepatoprotection


Research Use Disclaimer

This product is for research and laboratory use only. It is not approved for therapeutic, diagnostic, or veterinary use. Misuse may pose health and legal risks. Use only under institutional or laboratory supervision.

Additional information

Weight1 kg
Dimensions24 × 26 × 24 cm

Reviews

There are no reviews yet.

Be the first to review “Hymecromone Tablets 200?mg (Fujian / Wanbangde)”

Your email address will not be published. Required fields are marked *

EMI Options

Select at least 2 products
to compare